Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Garbutt

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
American Family Physician|December 16, 2006
Medications for the treatment of alcohol dependenceJames C Garbutt
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 26, 2019
Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United StatesJames C Garbutt
Journal of Substance Abuse Treatment|December 9, 2008
The state of pharmacotherapy for the treatment of alcohol dependenceJames C Garbutt
Current Pharmaceutical Design|May 21, 2010
Efficacy and tolerability of naltrexone in the management of alcohol dependenceJames C Garbutt
Frontiers in Psychiatry|October 10, 2018
Use of Baclofen for Alcohol Use Disorders in the United StatesJames C Garbutt
Lancet (London, England)|December 11, 2007
Baclofen for alcoholismJames C Garbutt, Barbara Flannery
The Medical Clinics of North America|June 5, 2017
Screening and Counseling for Unhealthy Alcohol Use in Primary Care SettingsDaniel E Jonas, James C Garbutt
CNS & Neurological Disorders Drug Targets|March 6, 2010
Effectiveness and safety of baclofen in the treatment of alcohol dependent patientsLorenzo Leggio, James C Garbutt, Giovanni Addolorato
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 17, 2021
Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young AdultsAlexei Kampov-Polevoy, Georgiy Bobashev, James C Garbutt
Neuroimage. Clinical|September 5, 2021
Risk and resilience for alcohol use disorder revealed in brain functional connectivityAmanda Elton, James C Garbutt, Charlotte A Boettiger
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
American Family Physician|December 16, 2006
Medications for the treatment of alcohol dependenceJames C Garbutt
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 26, 2019
Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United StatesJames C Garbutt
Journal of Substance Abuse Treatment|December 9, 2008
The state of pharmacotherapy for the treatment of alcohol dependenceJames C Garbutt
Current Pharmaceutical Design|May 21, 2010
Efficacy and tolerability of naltrexone in the management of alcohol dependenceJames C Garbutt
Frontiers in Psychiatry|October 10, 2018
Use of Baclofen for Alcohol Use Disorders in the United StatesJames C Garbutt
Lancet (London, England)|December 11, 2007
Baclofen for alcoholismJames C Garbutt, Barbara Flannery
The Medical Clinics of North America|June 5, 2017
Screening and Counseling for Unhealthy Alcohol Use in Primary Care SettingsDaniel E Jonas, James C Garbutt
CNS & Neurological Disorders Drug Targets|March 6, 2010
Effectiveness and safety of baclofen in the treatment of alcohol dependent patientsLorenzo Leggio, James C Garbutt, Giovanni Addolorato
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 17, 2021
Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young AdultsAlexei Kampov-Polevoy, Georgiy Bobashev, James C Garbutt
Neuroimage. Clinical|September 5, 2021
Risk and resilience for alcohol use disorder revealed in brain functional connectivityAmanda Elton, James C Garbutt, Charlotte A Boettiger
Pageof 5